Treace Medical Concepts, Inc.

TMCI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$16-$17-$16-$1
Dep. & Amort.$3$2$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$8$10$9$0
Change in WC-$1$1$8-$17
Other Non-Cash-$3$1$1$11
Operating Cash Flow-$9-$3$4-$4
Investing Activities
PP&E Inv.-$3-$5-$4-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$15-$15-$19
Inv. Sales/Matur.$0$17$17$25
Other Inv. Act.$12$0$0$0
Investing Cash Flow$9-$3-$2$3
Financing Activities
Debt Repay.$0$1$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0-$0
Financing Cash Flow-$0$1-$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$0-$5$2-$1
Supplemental Information
Beg. Cash$8$13$11$12
End Cash$8$8$13$11
Free Cash Flow-$12-$8$1-$7
Treace Medical Concepts, Inc. (TMCI) Financial Statements & Key Stats | AlphaPilot